FDA Scientists Oppose Plan to Ease Access to Unproven Peptide Drugs
UKPulse Health Desk
A plan to give people in the US easier access to unproven peptide drugs was opposed by most FDA scientific staff members, who had limited input in drafting the policy.
- The plan was driven almost entirely by HHS and faced overwhelming pushback among FDA drug staffers.
- The peptides in question have not been approved as safe and effective by the FDA.
A plan to give people in the US easier access to unproven peptide drugs favored by Robert F Kennedy Jr was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy.
The document posted online by HHS covers a handful of injectable peptides promoted within the wellness industry for building muscle, healing injuries and boosting energy.
Why this matters: The plan could undermine the FDA's mission of keeping unproven health products off the US market.
What this means for you: If you're considering using peptide injections, be aware that they have not been approved as safe and effective by the FDA.